Skip to main content
Top
Published in: Virchows Archiv 3/2010

01-03-2010 | Original Article

A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas

Authors: Stefanie Burghaus, Annett Hölsken, Michael Buchfelder, Rudolf Fahlbusch, Beat M. Riederer, Volkmar Hans, Ingmar Blümcke, Rolf Buslei

Published in: Virchows Archiv | Issue 3/2010

Login to get access

Abstract

Craniopharyngiomas (CP) are benign epithelial tumors of the sellar region and can be clinicopathologically distinguished into adamantinomatous (adaCP) and papillary (papCP) variants. Both subtypes are classified according to the World Health Organization grade I, but their irregular digitate brain infiltration makes any complete surgical resection difficult to obtain. Herein, we characterized the cellular interface between the tumor and the surrounding brain tissue in 48 CP (41 adaCP and seven papCP) compared to non-neuroepithelial tumors, i.e., 12 cavernous hemangiomas, 10 meningiomas, and 14 metastases using antibodies directed against glial fibrillary acid protein (GFAP), vimentin, nestin, microtubule-associated protein 2 (MAP2) splice variants, and tenascin-C. We identified a specific cell population characterized by the coexpression of nestin, MAP2, and GFAP within the invasion niche of the adamantinomatous subtype. This was especially prominent along the finger-like protrusions. A similar population of presumably astroglial precursors was not visible in other lesions under study, which characterize them as distinct histopathological feature of adaCP. Furthermore, the outer tumor cell layer of adaCP showed a distinct expression of MAP2, a novel finding helpful in the differential diagnosis of epithelial tumors in the sellar region. Our data support the hypothesis that adaCP, unlike other non-neuroepithelial tumors of the central nervous system, create a tumor-specific cellular environment at the tumor–brain junction. Whether this facilitates the characteristic infiltrative growth pattern or is the consequence of an activated Wnt signaling pathway, detectable in 90% of these tumors, will need further consideration.
Literature
1.
go back to reference Bunin GR, Surawicz TS, Witman PA et al (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:547–551CrossRefPubMed Bunin GR, Surawicz TS, Witman PA et al (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:547–551CrossRefPubMed
2.
go back to reference Kuratsu J, Ushio Y (1996) Epidemiological study of primary intracranial tumors in childhood. A population-based survey in Kumamoto Prefecture, Japan. Pediatr Neurosurg 25:240–246, discussion 247CrossRefPubMed Kuratsu J, Ushio Y (1996) Epidemiological study of primary intracranial tumors in childhood. A population-based survey in Kumamoto Prefecture, Japan. Pediatr Neurosurg 25:240–246, discussion 247CrossRefPubMed
3.
go back to reference Adamson TE, Wiestler OD, Kleihues P et al (1990) Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 73:12–17CrossRefPubMed Adamson TE, Wiestler OD, Kleihues P et al (1990) Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 73:12–17CrossRefPubMed
4.
go back to reference Sekine S, Shibata T, Kokubu A et al (2002) Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 161:1997–2001PubMed Sekine S, Shibata T, Kokubu A et al (2002) Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 161:1997–2001PubMed
5.
go back to reference Kato K, Nakatani Y, Kanno H et al (2004) Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 203:814–821CrossRefPubMed Kato K, Nakatani Y, Kanno H et al (2004) Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 203:814–821CrossRefPubMed
6.
go back to reference Buslei R, Nolde M, Hofmann B et al (2005) Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol (Berl) 109:589–597CrossRef Buslei R, Nolde M, Hofmann B et al (2005) Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol (Berl) 109:589–597CrossRef
7.
go back to reference Hofmann BM, Kreutzer J, Saeger W et al (2006) Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol 30:1595–1603CrossRefPubMed Hofmann BM, Kreutzer J, Saeger W et al (2006) Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol 30:1595–1603CrossRefPubMed
8.
go back to reference Kendall-Taylor P, Jonsson PJ, Abs R et al (2005) The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 152:557–567CrossRefPubMed Kendall-Taylor P, Jonsson PJ, Abs R et al (2005) The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 152:557–567CrossRefPubMed
10.
go back to reference Gleeson H, Amin R, Maghnie M (2008) ‘Do no harm’: management of craniopharyngioma. Eur J Endocrinol 159(Suppl 1):S95–S99CrossRefPubMed Gleeson H, Amin R, Maghnie M (2008) ‘Do no harm’: management of craniopharyngioma. Eur J Endocrinol 159(Suppl 1):S95–S99CrossRefPubMed
11.
go back to reference Muller HL (2008) Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res 69:193–202CrossRefPubMed Muller HL (2008) Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res 69:193–202CrossRefPubMed
12.
go back to reference Fahlbusch R, Hofmann BM (2008) Surgical management of giant craniopharyngiomas. Acta Neurochir (Wien) 150:1213–1226CrossRef Fahlbusch R, Hofmann BM (2008) Surgical management of giant craniopharyngiomas. Acta Neurochir (Wien) 150:1213–1226CrossRef
13.
go back to reference Kawamata T, Kubo O, Hori T (2005) Histological findings at the boundary of craniopharyngiomas. Brain Tumor Pathol 22:75–78CrossRefPubMed Kawamata T, Kubo O, Hori T (2005) Histological findings at the boundary of craniopharyngiomas. Brain Tumor Pathol 22:75–78CrossRefPubMed
14.
go back to reference Fahlbusch R, Honegger J, Paulus W et al (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90:237–250CrossRefPubMed Fahlbusch R, Honegger J, Paulus W et al (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90:237–250CrossRefPubMed
15.
go back to reference Muller HL, Albanese A, Calaminus G et al (2006) Consensus and perspectives on treatment strategies in childhood craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova, 2004. J Pediatr Endocrinol Metab 19(Suppl 1):453–454PubMed Muller HL, Albanese A, Calaminus G et al (2006) Consensus and perspectives on treatment strategies in childhood craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova, 2004. J Pediatr Endocrinol Metab 19(Suppl 1):453–454PubMed
16.
go back to reference Garre ML, Cama A (2007) Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr 19:471–479CrossRefPubMed Garre ML, Cama A (2007) Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr 19:471–479CrossRefPubMed
17.
go back to reference Puget S, Garnett M, Wray A et al (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 106:3–12PubMed Puget S, Garnett M, Wray A et al (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 106:3–12PubMed
18.
go back to reference Lendahl U, Zimmerman LB, McKay RD (1990) CNS stem cells express a new class of intermediate filament protein. Cell 60:585–595CrossRefPubMed Lendahl U, Zimmerman LB, McKay RD (1990) CNS stem cells express a new class of intermediate filament protein. Cell 60:585–595CrossRefPubMed
19.
go back to reference Wei LC, Shi M, Chen LW et al (2002) Nestin-containing cells express glial fibrillary acidic protein in the proliferative regions of central nervous system of postnatal developing and adult mice. Brain Res Dev Brain Res 139:9–17CrossRefPubMed Wei LC, Shi M, Chen LW et al (2002) Nestin-containing cells express glial fibrillary acidic protein in the proliferative regions of central nervous system of postnatal developing and adult mice. Brain Res Dev Brain Res 139:9–17CrossRefPubMed
20.
go back to reference Messam CA, Hou J, Berman JW et al (2002) Analysis of the temporal expression of nestin in human fetal brain derived neuronal and glial progenitor cells. Brain Res Dev Brain Res 134:87–92CrossRefPubMed Messam CA, Hou J, Berman JW et al (2002) Analysis of the temporal expression of nestin in human fetal brain derived neuronal and glial progenitor cells. Brain Res Dev Brain Res 134:87–92CrossRefPubMed
21.
go back to reference Sugawara K, Kurihara H, Negishi M et al (2002) Nestin as a marker for proliferative endothelium in gliomas. Lab Invest 82:345–351PubMed Sugawara K, Kurihara H, Negishi M et al (2002) Nestin as a marker for proliferative endothelium in gliomas. Lab Invest 82:345–351PubMed
22.
go back to reference Erickson HP, Bourdon MA (1989) Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol 5:71–92CrossRefPubMed Erickson HP, Bourdon MA (1989) Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol 5:71–92CrossRefPubMed
23.
go back to reference Gu H, Wang S, Messam CA et al (2002) Distribution of nestin immunoreactivity in the normal adult human forebrain. Brain Res 943:174–180CrossRefPubMed Gu H, Wang S, Messam CA et al (2002) Distribution of nestin immunoreactivity in the normal adult human forebrain. Brain Res 943:174–180CrossRefPubMed
24.
go back to reference Joester A, Faissner A (2001) The structure and function of tenascins in the nervous system. Matrix Biol 20:13–22CrossRefPubMed Joester A, Faissner A (2001) The structure and function of tenascins in the nervous system. Matrix Biol 20:13–22CrossRefPubMed
25.
go back to reference Scheffler B, Faissner A, Beck H et al (1997) Hippocampal loss of tenascin boundaries in Ammon's horn sclerosis. Glia 19:35–46CrossRefPubMed Scheffler B, Faissner A, Beck H et al (1997) Hippocampal loss of tenascin boundaries in Ammon's horn sclerosis. Glia 19:35–46CrossRefPubMed
26.
go back to reference Reardon DA, Zalutsky MR, Bigner DD (2007) Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients. Expert Rev Anticancer Ther 7:675–687CrossRefPubMed Reardon DA, Zalutsky MR, Bigner DD (2007) Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients. Expert Rev Anticancer Ther 7:675–687CrossRefPubMed
27.
go back to reference Liu HY, Nur EKA, Schachner M et al (2005) Neurite guidance by the FnC repeat of human tenascin-C: neurite attraction vs. neurite retention. Eur J Neurosci 22:1863–1872CrossRefPubMed Liu HY, Nur EKA, Schachner M et al (2005) Neurite guidance by the FnC repeat of human tenascin-C: neurite attraction vs. neurite retention. Eur J Neurosci 22:1863–1872CrossRefPubMed
28.
go back to reference Riederer B, Matus A (1985) Differential expression of distinct microtubule-associated proteins during brain development. Proc Natl Acad Sci U S A 82:6006–6009CrossRefPubMed Riederer B, Matus A (1985) Differential expression of distinct microtubule-associated proteins during brain development. Proc Natl Acad Sci U S A 82:6006–6009CrossRefPubMed
29.
go back to reference Riederer BM, Barakat-Walter I (1992) Differential distribution of two microtubule-associated proteins, MAP2 and MAP5, during chick dorsal root ganglion development in situ and in culture. Brain Res Dev Brain Res 68:111–123CrossRefPubMed Riederer BM, Barakat-Walter I (1992) Differential distribution of two microtubule-associated proteins, MAP2 and MAP5, during chick dorsal root ganglion development in situ and in culture. Brain Res Dev Brain Res 68:111–123CrossRefPubMed
30.
go back to reference Ferralli J, Doll T, Matus A (1994) Sequence analysis of MAP2 function in living cells. J Cell Sci 107(Pt 11):3115–3125PubMed Ferralli J, Doll T, Matus A (1994) Sequence analysis of MAP2 function in living cells. J Cell Sci 107(Pt 11):3115–3125PubMed
31.
go back to reference Kindler S, Schulz B, Goedert M et al (1990) Molecular structure of microtubule-associated protein 2b and 2c from rat brain. J Biol Chem 265:19679–19684PubMed Kindler S, Schulz B, Goedert M et al (1990) Molecular structure of microtubule-associated protein 2b and 2c from rat brain. J Biol Chem 265:19679–19684PubMed
32.
go back to reference Kalcheva N, Albala J, O'Guin K et al (1995) Genomic structure of human microtubule-associated protein 2 (MAP-2) and characterization of additional MAP-2 isoforms. Proc Natl Acad Sci U S A 92:10894–10898CrossRefPubMed Kalcheva N, Albala J, O'Guin K et al (1995) Genomic structure of human microtubule-associated protein 2 (MAP-2) and characterization of additional MAP-2 isoforms. Proc Natl Acad Sci U S A 92:10894–10898CrossRefPubMed
33.
go back to reference Shafit-Zagardo B, Davies P, Rockwood J et al (2000) Novel microtubule-associated protein-2 isoform is expressed early in human oligodendrocyte maturation. Glia 29:233–245CrossRefPubMed Shafit-Zagardo B, Davies P, Rockwood J et al (2000) Novel microtubule-associated protein-2 isoform is expressed early in human oligodendrocyte maturation. Glia 29:233–245CrossRefPubMed
34.
go back to reference Blumcke I, Muller S, Buslei R et al (2004) Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors. Acta Neuropathol (Berl) 108:89–96CrossRef Blumcke I, Muller S, Buslei R et al (2004) Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors. Acta Neuropathol (Berl) 108:89–96CrossRef
35.
go back to reference Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109CrossRefPubMed Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109CrossRefPubMed
36.
go back to reference Blumcke I, Becker AJ, Normann S et al (2001) Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells. J Neuropathol Exp Neurol 60:984–993PubMed Blumcke I, Becker AJ, Normann S et al (2001) Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells. J Neuropathol Exp Neurol 60:984–993PubMed
37.
go back to reference Yasuda Y, Fujita S (2003) Distribution of MAP1A, MAP1B, and MAP2A&B during layer formation in the optic tectum of developing chick embryos. Cell Tissue Res 314:315–324CrossRefPubMed Yasuda Y, Fujita S (2003) Distribution of MAP1A, MAP1B, and MAP2A&B during layer formation in the optic tectum of developing chick embryos. Cell Tissue Res 314:315–324CrossRefPubMed
38.
go back to reference Buslei R, Holsken A, Hofmann B et al (2007) Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol (Berl) 113:585–590CrossRef Buslei R, Holsken A, Hofmann B et al (2007) Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol (Berl) 113:585–590CrossRef
39.
go back to reference Lefranc F, Mijatovic T, Decaestecker C et al (2005) Monitoring the expression profiles of integrins and adhesion/growth-regulatory galectins in adamantinomatous craniopharyngiomas: their ability to regulate tumor adhesiveness to urrounding tissue and their contribution to prognosis. Neurosurgery 56:763–776CrossRefPubMed Lefranc F, Mijatovic T, Decaestecker C et al (2005) Monitoring the expression profiles of integrins and adhesion/growth-regulatory galectins in adamantinomatous craniopharyngiomas: their ability to regulate tumor adhesiveness to urrounding tissue and their contribution to prognosis. Neurosurgery 56:763–776CrossRefPubMed
40.
go back to reference Rotondo F, Oniya K, Kovacs K et al (2005) MAP-2 expression in the human adenohypophysis and in pituitary adenomas. An immunohistochemical study. Pituitary 8:75–79CrossRefPubMed Rotondo F, Oniya K, Kovacs K et al (2005) MAP-2 expression in the human adenohypophysis and in pituitary adenomas. An immunohistochemical study. Pituitary 8:75–79CrossRefPubMed
41.
go back to reference Weiner HL, Wisoff JH, Rosenberg ME et al (1994) Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 35:1001–1010, discussion 1010–1011CrossRefPubMed Weiner HL, Wisoff JH, Rosenberg ME et al (1994) Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 35:1001–1010, discussion 1010–1011CrossRefPubMed
42.
go back to reference Crotty TB, Scheithauer BW, Young WF Jr (1995) Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 83:206–214CrossRefPubMed Crotty TB, Scheithauer BW, Young WF Jr (1995) Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 83:206–214CrossRefPubMed
43.
44.
go back to reference Liszczak T, Richardson EP Jr, Phillips JP et al (1978) Morphological, biochemical, ultrastructural, tissue culture and clinical observations of typical and aggressive craniopharyngiomas. Acta Neuropathol 43:191–203PubMed Liszczak T, Richardson EP Jr, Phillips JP et al (1978) Morphological, biochemical, ultrastructural, tissue culture and clinical observations of typical and aggressive craniopharyngiomas. Acta Neuropathol 43:191–203PubMed
45.
go back to reference Karavitaki N, Brufani C, Warner JT et al (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62:397–409CrossRef Karavitaki N, Brufani C, Warner JT et al (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62:397–409CrossRef
46.
go back to reference Rutka JT, Apodaca G, Stern R et al (1988) The extracellular matrix of the central and peripheral nervous systems: structure and function. J Neurosurg 69:155–170CrossRefPubMed Rutka JT, Apodaca G, Stern R et al (1988) The extracellular matrix of the central and peripheral nervous systems: structure and function. J Neurosurg 69:155–170CrossRefPubMed
47.
go back to reference Giese A, Rief MD, Loo MA et al (1994) Determinants of human astrocytoma migration. Cancer Res 54:3897–3904PubMed Giese A, Rief MD, Loo MA et al (1994) Determinants of human astrocytoma migration. Cancer Res 54:3897–3904PubMed
48.
go back to reference Shafit-Zagardo B, Kress Y, Zhao ML et al (1999) A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions. J Neurochem 73:2531–2537CrossRefPubMed Shafit-Zagardo B, Kress Y, Zhao ML et al (1999) A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions. J Neurochem 73:2531–2537CrossRefPubMed
49.
go back to reference Cosenza MA, Zhao ML, Shankar SL et al (2002) Up-regulation of MAP2e-expressing oligodendrocytes in the white matter of patients with HIV-1 encephalitis. Neuropathol Appl Neurobiol 28:480–488CrossRefPubMed Cosenza MA, Zhao ML, Shankar SL et al (2002) Up-regulation of MAP2e-expressing oligodendrocytes in the white matter of patients with HIV-1 encephalitis. Neuropathol Appl Neurobiol 28:480–488CrossRefPubMed
50.
go back to reference Toma JG, Akhavan M, Fernandes KJ et al (2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3:778–784CrossRefPubMed Toma JG, Akhavan M, Fernandes KJ et al (2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3:778–784CrossRefPubMed
51.
go back to reference Kim SY, Lee SH, Kim BM et al (2004) Activation of nestin-positive duct stem (NPDS) cells in pancreas upon neogenic motivation and possible cytodifferentiation into insulin-secreting cells from NPDS cells. Dev Dyn 230:1–11CrossRefPubMed Kim SY, Lee SH, Kim BM et al (2004) Activation of nestin-positive duct stem (NPDS) cells in pancreas upon neogenic motivation and possible cytodifferentiation into insulin-secreting cells from NPDS cells. Dev Dyn 230:1–11CrossRefPubMed
52.
go back to reference Krum JM, Rosenstein JM (1999) Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds. Exp Neurol 160:348–360CrossRefPubMed Krum JM, Rosenstein JM (1999) Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds. Exp Neurol 160:348–360CrossRefPubMed
53.
go back to reference Leins A, Riva P, Lindstedt R et al (2003) Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer 98:2430–2439CrossRefPubMed Leins A, Riva P, Lindstedt R et al (2003) Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer 98:2430–2439CrossRefPubMed
54.
go back to reference Sarkar S, Nuttall RK, Liu S et al (2006) Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res 66:11771–11780CrossRefPubMed Sarkar S, Nuttall RK, Liu S et al (2006) Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res 66:11771–11780CrossRefPubMed
55.
go back to reference Beiter K, Hiendlmeyer E, Brabletz T et al (2005) beta-Catenin regulates the expression of tenascin-C in human colorectal tumors. Oncogene 24:8200–8204PubMed Beiter K, Hiendlmeyer E, Brabletz T et al (2005) beta-Catenin regulates the expression of tenascin-C in human colorectal tumors. Oncogene 24:8200–8204PubMed
56.
go back to reference Faissner A, Steindler D (1995) Boundaries and inhibitory molecules in developing neural tissues. Glia 13:233–254CrossRefPubMed Faissner A, Steindler D (1995) Boundaries and inhibitory molecules in developing neural tissues. Glia 13:233–254CrossRefPubMed
57.
go back to reference O'Brien TF, Faissner A, Schachner M et al (1992) Afferent-boundary interactions in the developing neostriatal mosaic. Brain Res Dev Brain Res 65:259–267CrossRefPubMed O'Brien TF, Faissner A, Schachner M et al (1992) Afferent-boundary interactions in the developing neostriatal mosaic. Brain Res Dev Brain Res 65:259–267CrossRefPubMed
58.
go back to reference Freeman RS, Barone MC (2005) Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders. Curr Drug Targets CNS Neurol Disord 4:85–92CrossRefPubMed Freeman RS, Barone MC (2005) Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders. Curr Drug Targets CNS Neurol Disord 4:85–92CrossRefPubMed
59.
go back to reference Holsken A, Kreutzer J, Hofmann BM et al (2009) Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas. Brain Pathol 19(3):357–364CrossRefPubMed Holsken A, Kreutzer J, Hofmann BM et al (2009) Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas. Brain Pathol 19(3):357–364CrossRefPubMed
Metadata
Title
A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas
Authors
Stefanie Burghaus
Annett Hölsken
Michael Buchfelder
Rudolf Fahlbusch
Beat M. Riederer
Volkmar Hans
Ingmar Blümcke
Rolf Buslei
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 3/2010
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-009-0873-0

Other articles of this Issue 3/2010

Virchows Archiv 3/2010 Go to the issue